Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%) Cipla informs about company updates
Date: 06-03-2019Cipla has informed that the Company and its subsidiary Cipla USA, Inc., announced a phased launch of generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg) in the USA. The launch is a subject of ongoing litigation.
The above information is a part of company’s filings submitted to BSE.